TREA

90261228 - MINJUVI

Follow

Information

  • Trademark
  • 90261228
  • Serial Number
    90261228
  • Registration Number
    6625338
  • Filing Date
    October 17, 2020
    4 years ago
  • Registration Date
    January 25, 2022
    2 years ago
  • Transaction Date
    June 17, 2024
    7 months ago
  • Status Date
    January 25, 2022
    2 years ago
  • Published for Opposition Date
    November 09, 2021
    3 years ago
  • Location Date
    January 25, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GANDARA, KEYLA MARIA
  • Attorney Docket Number
    2854-T339US
    Attorney Name
    Frances M. Jagla
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
MINJUVI
Case File Statements
  • GS0051: Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
  • GS0421: Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Case File Event Statements
  • 10/21/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 11/27/2020 - 4 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 12/4/2020 - 4 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/1/2021 - 3 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 3/9/2021 - 3 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 9/28/2021 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/17/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/26/2021 - 3 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2021 - 3 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/26/2021 - 3 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/20/2021 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/28/2021 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/5/2021 - 3 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/20/2021 - 3 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/9/2021 - 3 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/9/2021 - 3 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/25/2022 - 2 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/17/2024 - 7 months ago
    20 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/17/2024 - 7 months ago
    19 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/17/2024 - 7 months ago
    22 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/17/2024 - 7 months ago
    21 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/17/2024 - 7 months ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/31/2024 - 11 months ago
    18 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN